WHO suspends remdesivir from list of medicines after warning against use on Covid-19 patients
The World Health Organisation (WHO) has suspended Gilead’s remdesivir from its list of medicines.
WHO said this on Friday.
Prior to the suspension of remdesivir, WHO had warned against its use on Covid-19 patients.
"Yes, we have suspended it from the PQ (prequalification list)," WHO media representative Tarik Jasarevic said in an emailed response. "The suspension is a signal to countries that WHO, in compliance with the treatment guidelines, does not recommend countries procure the drug for Covid."
In India, Gilead had signed non-exclusive deals with several pharma companies to boost the supply of remdesivir.